10/30 leader board - Lab Equip & Supplies Dir
 

Simplex Isolation Systems

Rating: 0 - Write A Review
14500 Miller Avenue
Fontana, CA 92336-1696
About Simplex Isolation Systems
  • For 35 years Simplex Isolation Systems has been creating cleanrooms, enclosures, strip doors and other barriers to protect mission critical environments. Simplex developed the 797 Cleanroom Enclosure specifically to offer compounding pharmacists a reliable, easy-to-clean enclosure that helps them meet the requirements of USP 797. All Simplex products are based on modular designs that allow for easy assembly and the ability to expand to meet your growing needs for isolation and containment. All frame materials are made from extruded 6063-T5 anodized aluminum. Wall material options include ABS, polycarbonate, aluminum composite, acrylic, tempered glass or a selection of transparent or colored vinyls. You can also choose from transparent materials that offer protection from electro-static discharge, as well as those that are Class 1 fire rated, with the lowest smoke and flame spread ratings available.
Competitors of Simplex Isolation Systems

  • Thunder Scientific Corp.

    Thunder Scientific® offers the industry's best solution to your humidity calibration workload. The world's leading manufacturer of NIST-proven, two-pressure humidity calibration systems, Thunder has offered a full line of humidity measurement equipment, software, and accessories for over 50... Read More

  • RJ Safety Supply Company

  • Static Clean International

    Manufacture static control products, including ionizers in the form of static bars and blowers that reduce static-related process problems. These problems include poor yields, parts sticking and particle attraction.
News about Simplex Isolation Systems

  • TMI ACQUIRES SIMPLEX ISOLATION SYSTEMS Posted

  • Data Center Expert and Simplex Draw Record Crowd to AFCOM Chapter Meeting Posted

  • Data Center Cooling – Simplex AirBlock Pays Off Posted

View all news  
9/23/20 Med Rec - Laboratory Equip
LabEquip_3:1_12.18.18
Pharma 10/26/2018